Tag: left atrial appendage closure device market share

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Left Atrial Appendage Closure Device Market By 2029?

The market encompassing left atrial appendage closure devices has experienced swift expansion lately, projected to climb from a valuation of $1.67 billion in 2024 to $1.99 billion by 2025, reflecting a compound annual growth rate of 18.8 percent; this upward trajectory historically stems from factors such as the widespread occurrence of atrial fibrillation, increasing efforts toward stroke prophylaxis, the accumulation of supporting clinical data and ongoing investigations, the availability of less invasive procedural choices, a developing inclination among patients toward interventions that do not involve medication, the expanding demographic of older individuals, and the growing skill and proficiency among medical practitioners.

Anticipated swift expansion characterizes the market for left atrial appendage closure devices, projecting a valuation of $3.75 billion by 2029, fueled by a compound annual growth rate (CAGR) reaching 17.2%. This upward trajectory throughout the projection timeframe stems from the increasing worldwide prevalence of atrial fibrillation, heightened emphasis on preventing strokes among vulnerable patient populations, greater public understanding of the condition, the incorporation of these procedures into routine medical procedures, and worldwide initiatives aimed at better managing cardiovascular illnesses. Key developments anticipated during this period encompass the rise of catheter-based closure methods, progress in the engineering of these devices, greater reliance on diagnostic imaging tools, a push towards less invasive treatment options, and the customization of device choice according to individual patient anatomy.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13474&type=smp

Which Drivers Are Shaping The Left Atrial Appendage Closure Device Industry’s Market Share?

The increasing frequency of atrial fibrillation diagnoses is anticipated to be a key driver fueling the expansion of the left atrial appendage (LAA) closure device sector in the foreseeable future. Atrial fibrillation signifies an arrhythmia where the heart’s upper chambers, the atria, fail to contract synchronously and regularly, resulting in an erratic and frequently fast pulse. Devices designed for LAA closure are instrumental in managing this condition, chiefly by mitigating stroke hazards for individuals suffering from this heart rhythm irregularity and stopping the genesis or egress of thrombi. Illustratively, data released in October 2022 by the Centers for Disease Control and Prevention, a federal health entity in the United States, indicated that atrial fibrillation served as the primary reason for over 454,000 yearly hospital admissions across the US, and projections suggest that the number of American individuals diagnosed with atrial fibrillation will reach 12.1 million by the year 2030, thus underscoring why the growing occurrence of atrial fibrillation is set to boost the market for LAA closure medical technology.

Which Key Segments Fueling The Left Atrial Appendage Closure Device Market?

The left atrial appendage closure devicemarket covered in this report is segmented –

1) By Product: Epicardial Left Atrial Appendage (LAA) Devices, Endocardial Left Atrial Appendage (LAA) Devices

2) By Procedure: Percutaneous, Surgical

3) By End-User: Hospital, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Epicardial Left Atrial Appendage (LAA) Devices: Suture-Based Closure Devices, Ligation-Based Closure Devices, Clip-Based Closure Devices

2) By Endocardial Left Atrial Appendage (LAA) Devices: Plug-Based Closure Devices, Disc-Based Closure Devices, Mesh-Based Closure Devices

Which Key Trends Are Expected To Influence The Left Atrial Appendage Closure Device Market In The Coming Years?

Leading corporations within the sphere of left atrial appendage closure devices are currently pushing the boundaries of innovation by creating novel solutions, exemplified by the Watchman FLX, aimed at enhancing the care pathway for individuals afflicted with non-valvular atrial fibrillation (NVAF) and presenting a viable substitute for systemic oral anticoagulant regimens. Functioning as a self-expanding mechanism, the Watchman FLX implant is situated within the LAA for the explicit purpose of occluding its aperture, thereby mitigating the genesis of thromboemboli; specifically, in September 2022, Boston Scientific Corporation, an American manufacturer, secured clearance from the Food and Drug Administration, which is the federal body of the United States, to utilize the Watchman FLX for diminishing stroke probability in NVAF patients. This iteration boasts improved pliability and ease of placement compared to earlier Watchman models, thus broadening its suitability for an expanded patient demographic, furthermore solidifying its standing as a secure and efficacious method for mitigating stroke hazards among those diagnosed with NVAF, presenting a significant therapeutic choice for individuals unable to take, or struggling to adhere to, prescribed oral anticoagulants.

Which Key Players Are Driving Competition In The Left Atrial Appendage Closure Device Market?

Major companies operating in the left atrial appendage closure device market report are Johnson And Johnson Pvt Ltd., Abbott Laboratories, Medtronic plc., Atrium Medical Corporation, Boston Scientific Corporation, Gore Medical Inc., Lepu Medical Technology Co. Ltd., MicroPort Scientific Corporation, AtriCure Inc., Dune Medical Devices Ltd., Lifetech Scientific Corporation, Sahajanand Medical Technologies Limited, Occlutech, Cardiva Medical Inc., Sentreheart Inc., Aegis Medical Group, Coherex Medical Inc., EndoStim Inc., Conformal Medical Inc., Cardia Inc., Medical Device Business Service Inc., Protaryx Medical, Append Medical Ltd., Vascular Innovations Co. Ltd., Vivasure Medical Inc., Atritech Inc., CardiaMed AB, Cardialen Inc., Kalila Medical Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/left-atrial-appendage-closure-device-global-market-report

How Do Regional Market Performances Compare Within The Left Atrial Appendage Closure Device Industry?

North America was the largest region in the left atrial appendage closure devices market in 2024. The regions covered in the left atrial appendage closure device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Left Atrial Appendage Closure Device Market Report:

https://www.thebusinessresearchcompany.com/customise?id=13474&type=smp

Browse Through More Reports Similar to the Global Left Atrial Appendage Closure Device Market 2025, By The Business Research Company

Oncology Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/oncology-devices-global-market-report

Ophthalmic Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ophthalmic-devices-global-market-report

Orthopedic Braces And Support Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/orthopedic-braces-and-support-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#What Are the Key Projections for the CAGR of the Left Atrial Appendage Closure Device Market Size From 2025 to 2034?#_x000D_

The market size of the left atrial appendage closure device has seen substantial expansion in the previous years. The forecast predicts an increase from $1.67 billion in 2024 to $1.99 billion in 2025, witnessing a compound annual growth rate (CAGR) of 18.8%. The significant increase during the historic period can be linked to various factors such as the widespread incidence of atrial fibrillation, implementation of stroke prevention strategies, supportive clinical evidence, ongoing research, introduction of minimally invasive alternatives, patient inclination towards non-pharmacological options, an aging population, and improved physician skills and expertise._x000D_

_x000D_

In the coming years, the market size for left atrial appendage closure devices is projected to experience significant growth, potentially reaching $3.75 billion by 2029 with a compound annual growth rate (CAGR) of 17.2%. This growth during the forecast period can be linked to various factors such as the rising worldwide prevalence of atrial fibrillation, emphasis on preventing stroke in patients deemed high-risk, increased patient awareness, incorporation into routine clinical procedures and international efforts towards managing cardiovascular disease. Key trends anticipated for the forecast period are the emergence of percutaneous closure methods, progress in device design, the growing utilization of imaging technologies, a focus on less invasive procedures, and a personalized approach to device choice based on individual patient anatomy._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=13474&type=smp_x000D_

_x000D_

#What Are the Core Growth Drivers Propelling the Left Atrial Appendage Closure Device Market Forward?#_x000D_

The growth of the left atrial appendage (LAA) closure device market is anticipated to be driven by the increasing incidence of atrial fibrillation. Atrial fibrillation, a medical condition characterized by an irregular and often fast heartbeat, arises when the upper chambers of the heart, known as the atria, fail to beat rhythmically and in unison. LAA closure devices are commonly employed to manage atrial fibrillation by reducing stroke risk in individuals with this heart rhythm disorder and preventing the formation or release of blood clots. As an example, in October 2022, the Centers for Disease Control and Prevention, a US governing agency, reported that atrial fibrillation was the leading diagnosis in more than 454,000 hospital admissions annually in the US. It is also projected that by 2030, 12.1 million people in the US will suffer from atrial fibrillation. Consequently, this rising occurrence of atrial fibrillation is anticipated to drive the growth of the left atrial appendage (LAA) closure device market._x000D_

_x000D_

#What Segment Types Define the Left Atrial Appendage Closure Device Market Structure?#_x000D_

The left atrial appendage closure devicemarket covered in this report is segmented – _x000D_

_x000D_

1) By Product: Epicardial Left Atrial Appendage (LAA) Devices, Endocardial Left Atrial Appendage (LAA) Devices_x000D_

2) By Procedure: Percutaneous, Surgical_x000D_

3) By End-User: Hospital, Ambulatory Surgical Centers, Other End-Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Epicardial Left Atrial Appendage (LAA) Devices: Suture-Based Closure Devices, Ligation-Based Closure Devices, Clip-Based Closure Devices_x000D_

2) By Endocardial Left Atrial Appendage (LAA) Devices: Plug-Based Closure Devices, Disc-Based Closure Devices, Mesh-Based Closure Devices_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=13474&type=smp_x000D_

_x000D_

#Which Geographic Areas Hold the Strongest Growth Potential in the Left Atrial Appendage Closure Device Market?#_x000D_

North America was the largest region in the left atrial appendage closure devices market in 2024. The regions covered in the left atrial appendage closure device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Which Emerging Trends that Are Influencing theLeft Atrial Appendage Closure Device Industry Evolution?#_x000D_

Leading businesses in the left atrial appendage closure device market like Watchman FLX are introducing groundbreaking products to improve the treatment of non-valvular atrial fibrillation (NVAF) and offer an alternative to those who rely on oral anticoagulation therapy. The Watchman FLX pro device, which can be self-expanded and embedded in the LAA to stop blood clots from forming, received approval from the US based Food and Drug Administration in September 2022. This recognition was granted to the Boston Scientific Corporation, a US-based manufacturing company. The newly designed Watchman FLX is more flexible and easier to implant in comparison to its older models, making it a more feasible choice for a wider population. Moreover, it is deemed a safe and efficient method to minimize the risk of stroke in NVAF patients and a suitable option for those either ineligible for or having trouble managing their oral anticoagulation therapy._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/left-atrial-appendage-closure-device-global-market-report_x000D_

_x000D_

#What Is the Definition of the Left Atrial Appendage Closure Device Market?#_x000D_

A left atrial appendage closure device is a medical implant used to treat certain heart conditions, specifically in atrial fibrillation (AF) patients. These devices are implanted in a minimally invasive surgery to lower the risk of stroke in AF patients by sealing off or occluding the left atrial appendage (LAA), preventing blood from entering and clotting._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13474_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model